NAGIOS: RODERIC FUNCIONANDO

Oral bisphosphonate-associated osteonecrosis of maxillary bone: a review of 18 cases

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

Oral bisphosphonate-associated osteonecrosis of maxillary bone: a review of 18 cases

Mostra el registre parcial de l'element

dc.contributor.author López D'alessandro, Edgardo es
dc.contributor.author Mardenlli, Fabiana es
dc.contributor.author Paz, Marisa es
dc.contributor.author Escovich, Livia es
dc.date.accessioned 2015-01-20T09:11:50Z
dc.date.available 2015-01-20T09:11:50Z
dc.date.issued 2014 es
dc.identifier.citation López D'alessandro, Edgardo ; Mardenlli, Fabiana ; Paz, Marisa ; Escovich, Livia. Oral bisphosphonate-associated osteonecrosis of maxillary bone: a review of 18 cases. En: Journal of Clinical and Experimental Dentistry, 2014, Vol. 6, No. 5: 530-534 es
dc.identifier.uri http://hdl.handle.net/10550/41308
dc.description.abstract Biphosphonate-associated maxillary bone osteonecrosis (BPMO) is a complication related to nitrogen-containing biphosphonate therapy. This adverse effect occasionally appears in patients who are administered biphosphonates through intravenous infusion for the treatment of cancer involving bone metastases. It can also present, in a lesser degree, in patients who take these drugs orally for the treatment of osteoporosis. Lately, there has been an increase in the number of cases of osteopenia and osteoporosis due to the increasing life expectancy of the world's population. In our country, a risk group composed mainly of older women who have been diagnosed with osteopenia or osteoporosis, and submitted to the continuous action of oral biphosphonates, is emerging. In this paper we present 18 cases of BPMO associated to the use of oral biphosphonates, diagnosed and treated in the Department of Stomatology of the School or Dentistry at Universidad Nacional de Rosario, Argentina. A protocol was designed in which the following information was recorded: age and sex of the patients, the original disease which led to therapy with oral biphosphonates, the drugs used and the period in which those drugs were administered, the clinical features and location of the lesions, together with triggering factors. en_US
dc.subject Odontología es
dc.subject Ciencias de la salud es
dc.title Oral bisphosphonate-associated osteonecrosis of maxillary bone: a review of 18 cases es
dc.type journal article es_ES
dc.subject.unesco UNESCO::CIENCIAS MÉDICAS es
dc.type.hasVersion VoR es_ES

Visualització       (1.214Mb)

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Cerca a RODERIC

Cerca avançada

Visualitza

Estadístiques